Literature DB >> 10919669

Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects.

G De Vita1, M T Berlingieri, R Visconti, M D Castellone, G Viglietto, G Baldassarre, M Zannini, A Bellacosa, P N Tsichlis, A Fusco, M Santoro.   

Abstract

The Akt/protein kinase B serine/threonine kinase is a downstream effector of phosphoinositide 3-kinase (PI3K). Akt is an important component of mitogenic and antiapoptotic signaling pathways and is implicated in neoplastic transformation. Thyroid cells in culture retain a differentiated phenotype consisting of epithelial cell morphology and the expression of several tissue-specific genes. The survival and proliferation of these cells depend on thyrotropin and a mixture of five additional hormones that includes insulin. The regulation of proliferation and the expression of the thyroid differentiation program are intimately connected processes. As a result, oncogenes that induce hormone-independent proliferation invariably impair the expression of the thyroid-specific differentiation markers. Given that thyrotropin and insulin stimulate Akt activation in thyroid cells, we set out to determine the effects of Akt on thyroid cell proliferation, survival, and differentiation. To this end, we expressed constitutively active myristylated Akt (myrAkt) in PC Cl 3 thyroid cells. The myrAkt-expressing cells continued to proliferate, even in the absence of hormones, and they were resistant to programmed cell death induced by starvation. These effects were paralleled by the induction of the G1 cyclins D3 and E and by the inhibition of induction of the proapoptotic Fas, Fas ligand, and BAD genes in starved cells. However, in marked contrast with several other oncogenes, myrAkt did not interfere with the expression of thyroid differentiation functions. These results unveil the existence of an Akt-triggered thyroid cell pathway that modulates proliferation and survival without affecting the expression of the thyroid cell differentiated phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919669

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progression.

Authors:  Laurie S Spofford; Ethan V Abel; Karen Boisvert-Adamo; Andrew E Aplin
Journal:  J Biol Chem       Date:  2006-06-29       Impact factor: 5.157

2.  Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece.

Authors:  Elias Sozopoulos; Helen Litsiou; Gerassimos Voutsinas; Nikolaos Mitsiades; Nikolaos Anagnostakis; Thomais Tseva; Efstratios Patsouris; Sofia Tseleni-Balafouta
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

3.  Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Sophia Tseleni-Balafouta; Avi Ashkenazi; Demetrios A Koutras; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

4.  AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells.

Authors:  Madhu A Lal; Dongsoon Bae; Tura C Camilli; Steven R Patierno; Susan Ceryak
Journal:  Cell Cycle       Date:  2009-05-25       Impact factor: 4.534

Review 5.  Potential roles of GPR120 and its agonists in the management of diabetes.

Authors:  Dan Zhang; Po Sing Leung
Journal:  Drug Des Devel Ther       Date:  2014-07-29       Impact factor: 4.162

6.  Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue.

Authors:  Carly T Cederquist; Claudia Lentucci; Camila Martinez-Calejman; Vanessa Hayashi; Joseph Orofino; David Guertin; Susan K Fried; Mi-Jeong Lee; M Dafne Cardamone; Valentina Perissi
Journal:  Mol Metab       Date:  2016-10-31       Impact factor: 7.422

7.  Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas.

Authors:  R F Rodrigues; L Roque; J Rosa-Santos; O Cid; J Soares
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.